Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Ibn Alhaytham Hospital's average EBITDA Per Share Growth Rate was 16.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ibn Alhaytham Hospital was 56.50% per year. The lowest was -28.30% per year. And the median was -2.90% per year.
Ibn Alhaytham Hospital (AMM:IBNH) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Ibn Alhaytham Hospital 5-Year EBITDA Growth Rate Related Terms
AMM:IBNH vs HCA, THC, DVA: 5-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Ibn Alhaytham Hospital's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibn Alhaytham Hospital 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ibn Alhaytham Hospital's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Ibn Alhaytham Hospital's 5-Year EBITDA Growth Rate falls into.
Ibn Alhaytham Hospital 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Ibn Alhaytham Hospital (AMM:IBNH) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Ibn Alhaytham Hospital and its competitors.
Is Ibn Alhaytham Hospital's 5-Year EBITDA Growth Rate too high?
Ibn Alhaytham Hospital's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's 5-Year EBITDA Growth Rate compare to HCA and THC?
Ibn Alhaytham Hospital's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Ibn Alhaytham Hospital and its competitors. Ibn Alhaytham Hospital's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Ibn Alhaytham Hospital (AMM:IBNH) has a current 5-Year EBITDA Growth Rate of 0.00%. The stock's GF Value™ is JOD0.84, compared to a current price of JOD0.86 — trading 2.4% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued.
The current stock price of JOD0.86 is trading 2.4% above its estimated GF Value™ of JOD0.84.
Key valuation signals for AMM:IBNH:
5-Year EBITDA Growth Rate: 0.00%
GF Value™: JOD0.84 vs. price of JOD0.86 (2.4% above fair value)
No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score
Get the complete analysis for AMM:IBNH
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:IBNH has been successfully added to your 
